Immutep Competitors and Similar CompaniesClear all
Immutep's competitors and similar companies include OncoTherapy Science.
 Immutep Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment. |  OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics. | |
Founding Date | Founding Date 2001 | Founding Date 2001 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Sydney, AU HQ Sydney, AU The Rocks, AU Orsay, FR Berlin, DE Leipzig, DE | Locations Kawasaki, JP HQ |
Employees | Employees 2427% decrease | Employees 54 |
Valuation ($) | Valuation ($) 282.4 m | Valuation ($) 56.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥808.5m (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods ¥794.6m (FY, 2026) |
Gross profit | Gross profit $5m (FY, 2025) | Gross profit ¥14m (FY, 2026) |
Net income | Net income ($61.4m) (FY, 2025) | Net income (¥910.6m) (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
OncoTherapy Science
HQ
Kawasaki, JP
Employees
54
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
View company